The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Downregulation of CCND1 and CDK6 by miR‐34a induces cell cycle arrest
Abstract
miRNAs regulate gene expression by inhibiting translation or by targeting messenger RNA (mRNA) for degradation in a post‐transcriptional fashion. In the present study, we show that ectopic expression of miR‐34a reduces both mRNA and protein levels of cyclin D1 (CCND1) and cyclin‐dependent kinase 6 (CDK6). We also demonstrate that miR‐34a targets the 3′‐untranslated mRNA region of CCND1 as well as CDK6, which in turn interferes with phosphorylation of retinoblastoma. In addition, we show that overexpression of miR‐34a induces a significant G1 cell‐cycle arrest in the A549 cell line. Taken together, our data suggest that the effects of miR‐34a on G1 cell cycle arrest are through the down‐regulation of CCND1 and CDK6, which is associated with other targets of miR‐34a either additively or synergistically.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
microRNAs as oncogenes and tumor suppressors
Zhang, B., Pan, X., Cobb, G. P., & Anderson, T. A. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2006.08.028 · Cited by 2,749
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Chang, T.-C., Wentzel, E. A., Kent, O. A., Ramachandran, K., Mullendore, M., Lee, K. H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C. J., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.010 · Cited by 2,010
Ambros, V. (2001) · Cell · doi:10.1016/s0092-8674(01)00616-x · Cited by 1,697
The Pezcoller lecture: cancer cell cycles revisited.
Sherr, C. J. (2000) · PubMed · Cited by 1,409
Transcriptional Activation of miR-34a Contributes to p53-Mediated Apoptosis
Raver-Shapira, N., Marciano, E., Meiri, E., Spector, Y., Rosenfeld, N., Moskovits, N., Bentwich, Z., & Oren, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.017 · Cited by 1,352
p53-Mediated Activation of miRNA34 Candidate Tumor-Suppressor Genes
Bommer, G. T., Gerin, I., Feng, Y., Kaczorowski, A. J., Kuick, R., Love, R. E., Zhai, Y., Giordano, T. J., Qin, Z. S., Moore, B. B., et al. (2007) · Current Biology · doi:10.1016/j.cub.2007.06.068 · Cited by 1,123
Harbour, J. W., Luo, R. X., Santi, A. D., Postigo, A. A., & Dean, D. C. (1999) · Cell · doi:10.1016/s0092-8674(00)81519-6 · Cited by 1,057
MicroRNA-Cancer Connection: The Beginning of a New Tale
Calin, G. A., & Croce, C. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0800 · Cited by 1,053
The retinoblastoma protein is phosphorylated during specific phases of the cell cycle
Buchkovich, K., Duffy, L. A., & Harlow, E. (1989) · Cell · doi:10.1016/0092-8674(89)90508-4 · Cited by 995
Chen, P.-L., Scully, P., Shew, J.-Y., Wang, J. Y. J., & Lee, W.-H. (1989) · Cell · doi:10.1016/0092-8674(89)90517-5 · Cited by 952
Tarasov, V., Jung, P., Verdoodt, B., Lodygin, D., Epanchintsev, A., Menssen, A., Meister, G., & Hermeking, H. (2007) · Cell Cycle · doi:10.4161/cc.6.13.4436 · Cited by 923
Tazawa, H., Tsuchiya, N., Izumiya, M., & Nakagama, H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707351104 · Cited by 903
MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells
Welch, C., Chen, Y., & Stallings, R. L. (2007) · Oncogene · doi:10.1038/sj.onc.1210293 · Cited by 805
OncomiRs: the discovery and progress of microRNAs in cancers
Cho, W. C. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-60 · Cited by 719
Transcripts Targeted by the MicroRNA-16 Family Cooperatively Regulate Cell Cycle Progression
Linsley, P. S., Schelter, J., Burchard, J., Kibukawa, M., Martin, M. M., Bartz, S. R., Johnson, J. M., Cummins, J. M., Raymond, C. K., Dai, H., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02005-06 · Cited by 552
microRNAs join the p53 network — another piece in the tumour-suppression puzzle
He, L., He, X., Lowe, S. W., & Hannon, G. J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2232 · Cited by 547
Cycling to Cancer with Cyclin D1
Diehl, J. A. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.72 · Cited by 475
How Do MicroRNAs Regulate Gene Expression?
Jackson, R. J., & Standart, N. (2007) · Science's STKE · doi:10.1126/stke.3672007re1 · Cited by 475
Hammond, S. M. (2006) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.12.005 · Cited by 406
MicroRNAs and Cell Cycle Regulation
Carleton, M., Cleary, M. A., & Linsley, P. S. (2007) · Cell Cycle · doi:10.4161/cc.6.17.4641 · Cited by 343
Donnellan, R., & Chetty, R. (1998) · Molecular Pathology · doi:10.1136/mp.51.1.1 · Cited by 327
Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression
Tashiro, E., Tsuchiya, A., & Imoto, M. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00449.x · Cited by 270
MicroRNA and cancer: Current status and prospective
Wu, W., Sun, M., Zou, G., & Chen, J. (2007) · International Journal of Cancer · doi:10.1002/ijc.22454 · Cited by 266
Regulation of p27Kip1by miRNA 221/222 in Glioblastoma
Gillies, J. K., & Lorimer, I. A. J. (2007) · Cell Cycle · doi:10.4161/cc.6.16.4526 · Cited by 259
miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia
Zanette, D. L., Rivadavia, F., Molfetta, G. A., Barbuzano, F. G., Proto-Siqueira, R., Falcão, R. P., Zago, M. A., & Silva-Jr, W. A. (2007) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2006005000179 · Cited by 251
From Cell Cycle to Differentiation: An Expanding Role for Cdk6
Grossel, M. J., & Hinds, P. W. (2005) · Cell Cycle · doi:10.4161/cc.5.3.2385 · Cited by 97
Cyclins and related kinases in cancer cells.
Malumbres, M. (2007) · PubMed · Cited by 38
Michalides, R. J. A. M. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199908)188:4<341::aid-path384>3.0.co;2-1 · Cited by 14
Cited by
Targeting microRNAs in cancer: rationale, strategies and challenges
Garzon, R., Marcucci, G., & Croce, C. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3179 · Cited by 1,493
Nagy, Á., Lánczky, A., Menyhárt, O., & Győrffy, B. (2018) · Scientific Reports · doi:10.1038/s41598-018-27521-y · Cited by 1,319
The miR-34 family in cancer and apoptosis
Hermeking, H. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.56 · Cited by 1,236
Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer
Lodygin, D., Tarasov, V., Epanchintsev, A., Berking, C., Knyazeva, T., Körner, H., Knyazev, P., Diebold, J., & Hermeking, H. (2008) · Cell Cycle · doi:10.4161/cc.7.16.6533 · Cited by 784
miR-34 – a microRNA replacement therapy is headed to the clinic
Bader, A. G. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00120 · Cited by 728
Metadata
- Authors
- Sun, F., Fu, H., Liu, Q., Tie, Y., Zhu, J., Xing, R., Sun, Z., & Zheng, X.
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 2008-04-10
- Volume
- 582
- Issue
- 10
- Pages
- 1564-1568
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W2031475327
- Cited by
- 514
- References
- 30
- FWCI
- 10.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.